News

Afatinib has also been granted orphan drug designation by the FDA – a status given to a product intended for the treatment of a rare disease or condition.

As previously announced, the investigational drug was granted FDA Fast Track designation for the treatment of recurrent high-grade glioma, which includes glioblastoma and anaplastic astrocytoma, and is poised

Respreeza, a highly purified Alpha-1 protein derived from human plasma, is the only Alpha-1 proteinase inhibitor that has been proven in a prospective double blind, placebo controlled trial

TAPROS is the Prostaglandin F2a Analogue co-developed by Santen and Asahi Glass Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo) for the reduction of intraocular pressure (IOP) in glaucoma and ocular

An additional clinical trial site has been added by the company in the UK to ease travel burden for affected individuals living in the European Union (EU). FOP

The deal provides Shire with access to Sanquin’s manufacturing technology and allowing the Irish firm to source additional manufacturers to meet the growing demand for Cinryze. Shire CEO

The product, which is the generic version of Pfizer’s Zosyn injection, is a combination of penicillin-class antibacterial and beta-lactamase inhibitor. According to IMS Health, Piperacillin and Tazobactam for

Currently underway in multiple sites in Canada, the US and Asia, the trial is designed to evaluate TKM-PLK1’s safety and efficacy in treating patients with HCC. In the

The grant will allow the company to progress OCD155 through pre-clinical development towards clinical trials and to further unravel the mechanism-of-action, which will be done in a Dutch-Danish-German-Swiss